These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 15717260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM.
    Clin Infect Dis; 2007 Feb 15; 44(4):591-5. PubMed ID: 17243065
    [Abstract] [Full Text] [Related]

  • 4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.
    Infect Genet Evol; 2010 Apr 15; 10(3):356-64. PubMed ID: 19446658
    [Abstract] [Full Text] [Related]

  • 5. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C, Roulet V, Chueca N, Poveda E, Aguilera A, Skrabal K, Zahonero N, Carlos S, García F, Faudon JL, Soriano V, de Mendoza C.
    J Clin Microbiol; 2008 Mar 15; 46(3):887-91. PubMed ID: 18199789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV coreceptor phenotyping in the clinical setting.
    Low AJ, Swenson LC, Harrigan PR.
    AIDS Rev; 2008 Mar 15; 10(3):143-51. PubMed ID: 18820716
    [Abstract] [Full Text] [Related]

  • 12. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
    Karlsson U, Antonsson L, Ljungberg B, Medstrand P, Esbjörnsson J, Jansson M, Gisslen M.
    AIDS; 2012 Sep 10; 26(14):1739-44. PubMed ID: 22695299
    [Abstract] [Full Text] [Related]

  • 13. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
    Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA.
    Virology; 2000 Jun 05; 271(2):253-8. PubMed ID: 10860879
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in Spain.
    Moreno, Clotet, Sarría, Ortega, Leal, Rodriguez-Arrondo, Sánchez-de la Rosa, Allegro Study Group.
    HIV Clin Trials; 2009 Jun 05; 10(6):394-402. PubMed ID: 20133270
    [Abstract] [Full Text] [Related]

  • 15. Determination of HIV-1 coreceptor tropism in clinical practise.
    Foeglein A, Walter H.
    Eur J Med Res; 2007 Oct 15; 12(9):473-82. PubMed ID: 17933729
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.
    J Clin Virol; 2008 Sep 15; 43(1):25-31. PubMed ID: 18462992
    [Abstract] [Full Text] [Related]

  • 17. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
    Lathey JL, Brambilla D, Goodenow MM, Nokta M, Rasheed S, Siwak EB, Bremer JW, Huang DD, Yi Y, Reichelderfer PS, Collman RG.
    J Leukoc Biol; 2000 Sep 15; 68(3):324-30. PubMed ID: 10985247
    [Abstract] [Full Text] [Related]

  • 18. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.
    Brumme ZL, Goodrich J, Mayer HB, Brumme CJ, Henrick BM, Wynhoven B, Asselin JJ, Cheung PK, Hogg RS, Montaner JS, Harrigan PR.
    J Infect Dis; 2005 Aug 01; 192(3):466-74. PubMed ID: 15995960
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D, Müller D, Wolf T, Krause B, Meye B, Winskowsky G, Raupp S, Norley S, Brodt R, Werner A.
    J Med Virol; 2008 Feb 01; 80(2):192-200. PubMed ID: 18098144
    [Abstract] [Full Text] [Related]

  • 20. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
    Tscherning C, Alaeus A, Fredriksson R, Björndal A, Deng H, Littman DR, Fenyö EM, Albert J.
    Virology; 1998 Feb 15; 241(2):181-8. PubMed ID: 9499793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.